Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Docosahexaenoic acid (DHA, C22:6) is highly enriched in brain, synapses, and retina and is a major omega-3 fatty acid. Deficiencies in this essential fatty acid are reportedly associated with neuronal function, cancer, and inflammation. Here, using new lipidomic analyses employing high performance liquid chromatography coupled with a photodiode-array detector and a tandem mass spectrometer, a novel series of endogenous mediators was identified in blood, leukocytes, brain, and glial cells as 17S-hydroxy-containing docosanoids denoted as docosatrienes (the main bioactive member of the series was 10,17S-docosatriene) and 17S series resolvins. These novel mediators were biosynthesized via epoxide-containing intermediates and proved potent (pico- to nanomolar range) regulators of both leukocytes reducing infiltration in vivo and glial cells blocking their cytokine production. These results indicate that DHA is the precursor to potent protective mediators generated via enzymatic oxygenations to novel docosatrienes and 17S series resolvins that each regulate events of interest in inflammation and resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.](https://figures.cochat.ai/paper-figures/3022e35eb41542a6a28d8ac7db63b15b/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-3.png)



![FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).](https://figures.cochat.ai/paper-figures/b879709650c441a69692ab58e3270712/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-5.png)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMarchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Gunstone, F. D., Harwood, J. L., & Padley, F. B. (1994) · Cited by 1,010
Mechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Research works printed but not linked: 8
- Gallin, J. I., and Snyderman, R. (eds) (1999) Inflammation: Basic Principles and Clinical Correlates, Lippincott Williams & Wilkins, Philadelphia
- Bergstro ¨m, S. (1982) in Les Prix Nobel: Nobel Prizes, Presentations, Biogra- phies and Lectures, pp. 129 -148, Almqvist & Wiksell, Stockholm
- De Caterina, R., Endres, S., Kristensen, S. D., and Schmidt, E. B. (eds) (1993) n-3 Fatty Acids and Vascular Disease, Springer-Verlag, London
- Gronert, K., Clish, C. B., Romano, M., and Serhan, C. N. (1999) in Eicosanoid Protocols (Lianos, E. A., ed) pp. 119 -144, Humana Press, Totowa, NJ 28.
- Gronert, K., Colgan, S. P., and Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 285, 252-261
- Whelan, J., Reddanna, P., Nikolaev, V., Hildenbrandt, G. R., and Reddy, T. S. (1990) in Biological Oxidation Systems Vol. 2, pp. 765-778, Academic Press
- Bazan, N. G. (1990) in Nutrition and the Brain (Wurtman, R. J., and Wurtman, J. J., eds) Vol. 8, pp. 1-22, Raven Press, New York
- Bazan, N. G., and Rodriguez de Turco, E. B. (2001) in Neuroprotection (Lo, E. H., and Marwoh, J., eds) pp. 195, Prominent Press
Cited by
Items 301–400 of 997
Brain Response to Injury and Neurodegeneration: Endogenous Neuroprotective Signaling
BAZAN, N. G., MARCHESELLI, V. L., & COLE‐EDWARDS, K. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00018.x · Cited by 80
Farias, S. E., Basselin, M., Chang, L., Heidenreich, K. A., Rapoport, S. I., & Murphy, R. C. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800200-jlr200 · Cited by 80
Yacoubian, S., & Serhan, C. N. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0616 · Cited by 87
“Eicosapentaenoic acid and docosahexaenoic acid are widely known as omega-3 polyunsaturated fatty acids (PUFAs), or fish oils, and the new mediators can potently control the resolution of inflammatory exudates”
BackgroundSelf-citationBiosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair
Hellmann, J. L., Sansbury, B. E., Wong, B. C. K., Li, X., Singh, M., Nuutila, K., Chiang, N., Eriksson, E. K., Serhan, C. N., & Spite, M. R. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1498 · Cited by 83
“Indeed, we have previously shown that 17-HDHA is converted to D-series resolvins in human leukocytes (Hong et al., 2003; Spite et al., 2009).”
BackgroundResultSelf-citationStotts, C., Corrales‐Medina, V., & Rayner, K. J. (2023) · Circulation Research · doi:10.1161/circresaha.122.321636 · Cited by 100
The Inflammatory Role of Platelets in Cystic Fibrosis
O'Sullivan, B. P., & Michelson, A. D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1243pp · Cited by 79
Chiu, C., Gomolka, B., Dierkes, C., Huang, N. R., Schroeder, M., Purschke, M., Manstein, D., Dangi, B., & Weylandt, K. H. (2012) · Inflammation Research · doi:10.1007/s00011-012-0489-8 · Cited by 85
Resolution of inflammation in obesity-induced liver disease
Rius, B., López-Vicario, C., González-Périz, A., Morán-Salvador, E., García-Alonso, V., Clária, J., & Titos, E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00257 · Cited by 79
“Similarly, RvD1 and RvD2 were reported to reduce inflammatory pain, block IL-1β transcripts induced by TNFα in microglial cells and function as potent regulators limiting PMN infiltration into inflamed brain, skin, and peritoneum (Hong et al., 2003; Sun et al., 2007).”
BackgroundPanchaud, A., Sauty, A., Kernen, Y., Decosterd, L. A., Buclin, T., Boulat, O., Hug, C., Pilet, M., & Roulet, M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.10.011 · Cited by 81
Depletion of Brain Docosahexaenoic Acid Impairs Recovery from Traumatic Brain Injury
Desai, A., Kevala, K., & Kim, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086472 · Cited by 84
“Moreover, DHA has been shown to be converted to anti-inflammatory, proresolving and neuroprotective mediators, such as resolvins [7] and protectins [8].”
BackgroundResolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells
Li, L., Wu, Y., Wang, Y., Wu, J., Song, L., Xian, W., Yuan, S., Pei, L., & Shang, Y. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-72 · Cited by 77
“Resolvin D1 (7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-DHA, RvD1) is produced physiologically from the sequential oxygenation of DHA by 15-lipoxygenase and 5-lipoxygenase [16].”
BackgroundSignificance of lipid mediators in corneal injury and repair
Kenchegowda, S., & Bazán, H. E. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r001347 · Cited by 86
Skipped dienes in natural product synthesis
Petruncio, G., Shellnutt, Z., Elahi-Mohassel, S., Alishetty, S., & Paige, M. A. (2021) · Natural Product Reports · doi:10.1039/d1np00012h · Cited by 76
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis
Mehta, L. R., Dworkin, R. H., & Schwid, S. R. (2009) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro1009 · Cited by 75
Tian, H., Lu, Y., Sherwood, A. M., Hongqian, D., & Hong, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3146 · Cited by 76
“Lipid mediators were extracted and purified according to our established procedures.(11,12) Briefly, cells and medium of each sample were combined.”
BackgroundMethodInfluentialSelf-citationTransgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease
Bousquet, M., Gue, K., Emond, V., Julien, P., Kang, J. X., Cicchetti, F., & Calon, F. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011692 · Cited by 76
Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
Markworth, J. F., Brown, L. A., Lim, E. Y., Floyd, C., Larouche, J. A., Castor‐Macias, J. A., Sugg, K. B., Sarver, D. C., Macpherson, P. C. D., Davis, C. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137713 · Cited by 85
“We could not detect endogenous RvD1 in muscle but did observe increased expression of the enzymatic machinery for RvD1 biosynthesis (15- and 5-LOX) (24) and 17-HDoHE, the primary 15-LOX intermediate product of DHA produced during D-series resolvin biosynthesis (25) following injury.”
BackgroundMethodAbdelmoaty, S., Wigerblad, G., Bas, D. B., Codeluppi, S., Fernández-Zafra, T., El‐Awady, E., Moustafa, Y. M., Abdelhamid, A. E.-D. S., Brodin, E., & Svensson, C. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075543 · Cited by 79
“Given the anti-inflammatory properties of lipoxins and resolvins [8,25,36], it is not surprising that local or systemic injection of these factors prior to carrageenan injection reduces paw edema [2,4,37].”
BackgroundPotential Treatment of Parkinson’s Disease with Omega-3 Polyunsaturated Fatty Acids
Li, P., & Song, C. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1735143 · Cited by 74
“Recent literature has further reported that DHA derivatives are endowed with anti-inflammatory properties [71,72].”
BackgroundAnti-Inflammatory and Proresolving Effects of the Omega-6 Polyunsaturated Fatty Acid Adrenic Acid
Brouwers, H., Jónasdóttir, H. S., Kuipers, M. E., Kwekkeboom, J. C., Auger, J. L., González‐Torres, M. I., López‐Vicario, C., Clària, J., Freysdóttir, J., Harðardóttir, I., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1801653 · Cited by 76
Weylandt, K. H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.002 · Cited by 77
Koltsida, O., Karamnov, S., Pyrillou, K., Vickery, T., Chairakaki, A., Tamvakopoulos, C., Sideras, P., Serhan, C. N., & Andreakos, E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201891 · Cited by 72
“We found significant increases in 7-hydroxydocosahexaenoic acid (d5-7-HDHA), d5-14-HDHA and d5-17-HDHA (Fig 5), rate-limiting components in the metabolism of DHA to its bioactive derivatives (Hong et al, 2003; Miyata et al, 2013; Serhan et al, 2006).”
Self-citationParadigm Shift in the Pharmacological Management of Periodontal Diseases
Hasturk, H., Kantarci, A., & Van Dyke, T. E. (2012) · Frontiers of Oral Biology · doi:10.1159/000329678 · Cited by 73
Deore, G. D., Gurav, A. N., Patil, R., Shete, A., Naiktari, R. S., & Inamdar, S. P. (2014) · Journal of Periodontal & Implant Science · doi:10.5051/jpis.2014.44.1.25 · Cited by 79
“However, later work revealed that a novel series of lipid mediators, resolvins and protectins, is enzymatically converted by ω-3 PUFAs, which serve as substrates for the reaction [11,13-15].”
n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging
Joffre, C., Dinel, A., Chataigner, M., Pallet, V., & Layé, S. (2020) · Nutrients · doi:10.3390/nu12030647 · Cited by 83
Little, S. J., Lynch, M. A., Manku, M. S., & Nicolaou, A. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.08.009 · Cited by 73
Cheon, Y., Kim, H., Igarashi, M., Modi, H. R., Chang, L., Ma, K., GREENSTEIN, D. K., Wohltmann, M., TURK, J. W., Rapoport, S. I., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.02.003 · Cited by 78
DHA Metabolism: Targeting the Brain and Lipoxygenation
Picq, M., Chen, P., Perez, M., Michaud, M., Véricel, E., Guichardant, M., & Lagarde, M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8131-7 · Cited by 71
“The most bioactive of these have been termed resolvins because they promote the resolution of inflammation [6] and protectin D1 (PD1) or neuroprotectin D1 (NPD1) because of a potent anti-inflammatory potential [7] and potent neuroprotective effect [8], respectively.”
BackgroundMediator-lipidomics: databases and search algorithms for PUFA-derived mediators
Lu, Y., Hong, S., Tjonahen, E., & Serhan, C. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d400020-jlr200 · Cited by 71
“We routinely identify LMs by comparing the unknown spectra (MS/MS, GC-MS, and UV spectra) and CRTs with those of authentic and synthetic standards if available or with a theoretical database that consists of virtual UV and MS/MS spectra and CRTs for discovering potentially novel LMs (3, 4 , 12) if standards are not av…”
BackgroundMethodSelf-citationEmre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 70
“AD brains showed increased expression of 15-LOX-1 [104], and similarly, we found higher levels of this enzyme in the App KI mice at an age (18 months) when an increase in 15-HETE, 17-HDHA, and LXA4 levels, all of which are products of 15-LOX-1 enzyme activity, takes place [8, 29, 52].”
BackgroundProresolving lipid mediators: potential for prevention and treatment of periodontitis
Dyke, T. E. V. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01662.x · Cited by 81
15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?
Lee, S. I., Zuo, X., & Shureiqi, I. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9321-0 · Cited by 72
Ungaro, F., Rubbino, F., Danese, S., & D’Alessio, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01331 · Cited by 79
Liu, G., Tao, T., Wang, H., Zhou, Y., Gao, X., Gao, Y., Hang, C., & Li, W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01918-x · Cited by 74
Kim, H., Huang, B. X., & Spector, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094635 · Cited by 82
Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders
Lee, H., & Surh, Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.004 · Cited by 79
Messamore, E., Almeida, D. M., Jandacek, R. J., & McNamara, R. K. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.01.001 · Cited by 68
Dangi, B., Obeng, M., Nauroth, J. M., Teymourlouei, M., Needham, M., Raman, K., & Arterburn, L. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809014200 · Cited by 68
Balas, L., Guichardant, M., Durand, T., & Lagarde, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.006 · Cited by 74
Lee, H., Kundu, J. K., Cha, Y., & Surh, Y. (2013) · Journal of Cell Science · doi:10.1242/jcs.131003 · Cited by 83
“Resolvin D1 (RvD1) is one of the pro-resolving lipid mediators formed from docosahexaenoic acid (DHA; C22:6), a representative omega-3 fatty acid in sequential reactions catalyzed by 15-lipoxygenase (15-LOX) and 5-LOX (Hong et al., 2003).”
BackgroundVik, A., Dalli, J., & Hansen, T. V. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.079 · Cited by 72
Resolution of Inflammation in Periodontitis
Kantarcı, A., & Dyke, T. E. V. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.11-s.2168 · Cited by 77
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Vartak, T., Godson, C., & Brennan, E. P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113965 · Cited by 72
Omega-3 fatty acids and neurological injury
Michael-Titus, A. T. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.021 · Cited by 71
Weylandt, K. H., & Kang, J. X. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67119-x · Cited by 75
Petasis, N. A., Keledjian, R., Sun, Y., Venkata, K. C. N., Tjonahen, E., Yang, R., & Serhan, C. N. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.013 · Cited by 67
Self-citationLu, Y., Tian, H., & Hong, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000059 · Cited by 66
Self-citationSerhan, C. N. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.016 · Cited by 71
Self-citationResolution of Adipose Tissue Inflammation
González‐Périz, A., & Clària, J. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.77 · Cited by 78
Rosa, A. O., & Rapoport, S. I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.009 · Cited by 76
Effect of dietary omega‐3 polyunsaturated fatty acids on experimental periodontitis in the mouse
Bendyk, A., Marino, V., Zilm, P. S., Howe, P. R. C., & Bartold, P. M. (2009) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01108.x · Cited by 79
Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions
Kholy, K. E., Freire, M., Chen, T., & Dyke, T. E. V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01300 · Cited by 73
“Immune cells are regulated by specialized pro-resolving mediators (SPMs) (13–15), which were first characterized by unbiased systems approach to study acute inflammation and self-resolving inflammatory exudates (16, 17).”
BackgroundShi, J., Zhang, X., Jiang, L., Zhang, L., Dong, Y., Midgley, A. C., Kong, D., & Wang, S. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.037 · Cited by 65
Schwab, J. M., Schluesener, H. J., Meyermann, R., & Serhan, C. N. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.07.003 · Cited by 92
“Of interest, novel docosanoids coined docosatrienes and 17S series resolvins are generated in the brain and by leukocytes from DHA without aspirin treatment and also display potent antiinflammatory properties functioning within the pico- to nano-molar range in vitro and in vivo [17,22].”
BackgroundSelf-citationDiet and Inflammation in Alzheimer’s Disease and Related Chronic Diseases: A Review
Gardener, S. L., Rainey‐Smith, S. R., & Martins, R. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150765 · Cited by 70
Chen, F., Fan, X., Wu, Y., Zhu, J., Wang, F., Bo, L., Li, J. B., Bao, R., & Deng, X. M. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1978-6 · Cited by 68
Lipoxins in the eye and their role in wound healing
Gronert, K. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.009 · Cited by 69
Self-citationSerhan, C. N., de la Rosa, X., & Jouvene, C. C. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12871 · Cited by 70
Self-citationThe Role of Eicosanoids in Alzheimer’s Disease
Biringer, R. G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16142560 · Cited by 64
Mulik, R. S., Bing, C., Ladouceur-Wodzak, M., Munaweera, I., Chopra, R., & Corbin, I. R. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.021 · Cited by 64
Echeverría, F., Valenzuela, R., Bustamante, A., Álvarez, D., Ortíz, M., Soto-Alarcón, S. A., Muñoz, P., Corbari, A., & Videla, L. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5109503 · Cited by 72
“liver, producingmetabolic products such asDHA, E-resolvins [38], epoxy-derivatives [39], and/or J3 isoprostanes [40], thus limiting the concentration needed for cell signaling.”
Background‘PUFA–GPR40–CREB signaling’ hypothesis for the adult primate neurogenesis
Yamashima, T. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.02.001 · Cited by 71
Das, U. N. (2010) · Journal of Inflammation Research · doi:10.2147/jir.s9425 · Cited by 64
“Resolvins inhibited brain ischemia-reperfusion injury.(21,22) It is possible that LXs, resolvins, and protectins (docosanoids are also called as protectins because they have neuroprotective actions) behave as endogenous anti-inflammatory and cytoprotective molecules.”
Chen, P., Vãricel, E., Lagarde, M., & Guichardant, M. (2010) · The FASEB Journal · doi:10.1096/fj.10-161836 · Cited by 71
Protectins: Their biosynthesis, metabolism and structure-functions
Hansen, T. V., & Serhan, C. N. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115330 · Cited by 68
Self-citationTungen, J. E., Aursnes, M., Dalli, J., Arnardottir, H., Serhan, C. N., & Hansen, T. V. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201404721 · Cited by 62
Self-citationPGC-1α-mediated changes in phospholipid profiles of exercise-trained skeletal muscle
Senoo, N., Miyoshi, N., Goto‐Inoue, N., Minami, K., Yoshimura, R., Morita, A., Sawada, N., Matsuda, J., Ogawa, Y., Setou, M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060533 · Cited by 61
Kumar, A. P. R., Mastana, S. S., & Lindley, M. R. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422415000116 · Cited by 70
“PD1 has been reported to facilitate the expression of CCR5 ligands on neutrophils and to inhibit NF-κβ induction, which prevents the migration of neutrophils((156)).”
BackgroundBosviel, R., Joumard‐Cubizolles, L., Chinetti, G., Bayle, D., Copin, C., Hennuyer, N., Duplan, I., Staels, B., Zanoni, G., Porta, A., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.018 · Cited by 67
“1 to 200 nM, reduced from about 25–100% different types of pro-inflammatory markers (TNF-α, IL-6, COX-2, IL1-β, IFNγ, CEX-1 and B94) in mouse macrophages [40,41], in rat macrophages [49], in human peripheral blood T cells [50], in primary human neuro-glial cells [22], in human glioma cells [51] or in human neuron cell…”
BackgroundFirst total synthesis of 7(S),16(R),17(S)-Resolvin D2, a potent anti-inflammatory lipid mediator
Rodríguez, A. R., & Spur, B. W. (2004) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.09.129 · Cited by 63
Xie, W., Wang, H., Wang, L., Yao, C., Yuan, R., & Wu, Q. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.80 · Cited by 63
ER Stress and Effects of DHA as an ER Stress Inhibitor
Begum, G., Harvey, L. D., Dixon, C. E., & Sun, D. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0282-1 · Cited by 59
ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands
Nelson, J. W., Leigh, N. J., Mellas, R. E., McCall, A. D., Aguirre, A., & Baker, O. J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00284.2013 · Cited by 60
Kompauer, I., Demmelmair, H., Koletzko, B. V., Bolte, G., Linseisen, J., & Heinrich, J. (2008) · European Journal of Epidemiology · doi:10.1007/s10654-007-9218-y · Cited by 65
Derogis, P. B. M. C., Freitas, F. P., Marques, A. S. F., Cunha, D., Appolinário, P. P., de Paula, F., Lourenço, T. C., Murgu, M., Mascio, P. D., de Medeiros, M. H. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077561 · Cited by 65
“The isolated isomers were characterized by LC-MS/MS, and unique and specific fragment ions were chosen to construct a selected reaction monitoring (SRM) method for the targeted quantitative analysis of each HpDoHE and HDoHE isomer.”
BackgroundInfluentialWang, L., Yuan, R., Yao, C., Wu, Q., Christelle, M., Xie, W., Zhang, X., Sun, W., Wang, H., & Yao, S. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131044 · Cited by 67
“In a peritonitis model RvD1 inhibited neutrophil recruitment, modified the miRNA expression, reduced the expression of cytokines, and relieved inflammation associated with peritonitis.(8,9) RvD1 could also prevent neutrophil recruitment in a murine air pouch model.”
BackgroundMaskrey, B. H., Megson, I. L., Rossi, A. G., & Whitfield, P. D. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200723 · Cited by 69
Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages
Andersson, C., Zaman, M. M., Jones, A. B., & Freedman, S. D. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.05.004 · Cited by 60
Clària, J., González‐Périz, A., López‐Vicario, C., Rius, B., & Titos, E. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00049 · Cited by 80
“…DHA derivative, Frontiers in Immunology | Inflammation October 2011 | Volume 2 | Article 49 | 4 17S-hydroxy-DHA via an intermediate epoxide that opens via hydrolysis and subsequent rearrangements to form protectin D1 (10R,17S-dihydroxy-docosa-DHA) (Serhan et al., 2000, 2002; Hong et al., 2003).”
Backgroundde la Rosa, X., Norris, P. C., Chiang, N., Rodríguez, A. R., Spur, B. W., & Serhan, C. N. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.004 · Cited by 62
Self-citationInflammation, Lipid (Per)oxidation, and Redox Regulation
Dias, I. H. K., Milic, I., Heiß, C., Ademowo, O. S., Polidori, M. C., Devitt, A., & Griffiths, H. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8022 · Cited by 64
“In microglia, both ResD1 and its aspirin analog indirectly block synthesis of proinflammatory interleukin-1 b , which is rapidly released following brain injury (83).”
Tian, H., Lu, Y., Shah, S. P., & Hong, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100388 · Cited by 58
Self-citationPersistence of Essential Fatty Acid Deficiency in Cystic Fibrosis Despite Nutritional Therapy
Aldamiz-Echevarria, L. J., Prieto, J. A., Andrade, F., Elorz, J., Sojo, A., Lage, S., Sanjurjo, P., Vázquez, C., & Rodríguez‐Soriano, J. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b4e8d3 · Cited by 59
Lipoxins and resolvins in inflammatory bowel disease
Weylandt, K. H., Kang, J. X., Wiedenmann, B., & Baumgart, D. C. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20109 · Cited by 58
Hall, J. C. E., Priestley, J. V., Perry, V. H., & Michael-Titus, A. T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07726.x · Cited by 63
Finding Homes for Orphan Cytochrome P450s: CYP4V2 and CYP4F22 in Disease States
Kelly, E. J., Nakano, M., Rohatgi, P., Yarov-Yarovoy, V. M., & Rettie, A. E. (2011) · Molecular Interventions · doi:10.1124/mi.11.2.10 · Cited by 63
Eicosanoids and the endogenous control of acute inflammatory resolution
Gilroy, D. W. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.013 · Cited by 57
Xu, J., Duan, X., Hu, F., Poorun, D., Liu, X., Wang, X., Zhang, S., Gan, L., He, M. L., Zhu, K., et al. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.10.016 · Cited by 58
Recchiuti, A., Mattoscio, D., & Isopi, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00252 · Cited by 64
“…bioactivity than PD1 have also been identified: 10S,17S-diHDHA, 4S,17SdiHDHA, 7S,17S-diHDHA, and 22-hydrox-10,17S-docosatriene (Serhan et al., 2002; Hong et al., 2003), and an aspirin PD1 has been reported (Marcheselli et al., 2003) (10R,17R-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic…”
BackgroundVella, L. D., Markworth, J. F., Farnfield, M. M., Maddipati, K. R., Russell, A. P., & Cameron‐Smith, D. (2019) · Physiological Reports · doi:10.14814/phy2.14108 · Cited by 57
Markworth, J. F., Brown, L. A., Lim, E. Y., Castor‐Macias, J. A., Larouche, J. A., Macpherson, P. C. D., Davis, C. S., Aguilar, C. A., Maddipati, K. R., & Brooks, S. V. (2021) · Aging Cell · doi:10.1111/acel.13393 · Cited by 67
“(d) Shifts in the balance of major eicosanoids (TXB2, PGD2, PGE2, PGF2α, 6kPGF1α, and 5- , 12- , 15- HETEs) relative to detected pro- resolving mediators (RvE3, 8- oxoRvD1, LXA4, RvD6, PD1, PDX, and MaR1) and related pathway markers (5- , 18- HEPEs and 4- , 7- , 14, 17- HDoHEs) following muscle injury.”
InfluentialFatty Acid Synthesis in Glial Cells of the CNS
Corrales, A. V. G., Haidar, M., Bogie, J. F. J., & Hendriks, J. J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158159 · Cited by 61
“Microglia mediate synaptic pruning [94] and regulate neurogenesis and repair [95,96].”
BackgroundRoles of resolvins in the resolution of acute inflammation
Qu, Q., Xuan, W., & Fan, G.-H. (2014) · Cell Biology International · doi:10.1002/cbin.10345 · Cited by 65
“Briefly, DHA is initially converted by 15-LOX in human or 12/15-LOX in mice to17S-hydroxy-DHA (17S-HDHA) and 17S-hydroperoxyDHA (17S-HpDHA), which are transformed to RvDs and PD1 via 5-LOX, respectively (Hong et al., 2003).”
BackgroundMcNamara, R. K., Jandacek, R., Tso, P., Dwivedi, Y., Ren, X., & Pandey, G. N. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.007 · Cited by 56
“DHA is mobilized from membrane phospholipids by the calcium-independent phospholipase A2 (iPLA2) isoform (Farooqui & Horrocks, 2004) and free DHA is a substrate for anti-inflammatory docosanoids (Groeger et al., 2010; Hong et al., 2003).”
BackgroundYin, H., Liu, W., Goleniewska, K., Porter, N. A., Morrow, J. D., & Peebles, R. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.033 · Cited by 60
Acute Lung Injury Is Reduced in fat-1 Mice Endogenously Synthesizing n-3 Fatty Acids
Mayer, K., Kiessling, A., Ott, J., Schaefer, M. B., Hecker, M., Henneke, I., Schulz, R., Günther, A., Wang, J., Wu, L., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1064oc · Cited by 56
“Generation of this new class of EPA- or DHA-derived lipid mediators has already been demonstrated in fat-1 mice (58) and in human blood (59).”
BackgroundBiological Roles of Resolvins and Related Substances in the Resolution of Pain
Lim, J. Y., Park, C., & Hwang, S. W. (2015) · BioMed Research International · doi:10.1155/2015/830930 · Cited by 61
“In 15-lipoxygenase metabolism, DHA generates D series resolvins and NPD1 [85, 86].”
BackgroundZhang, X., Wang, T., Gui, P., Yao, C., Sun, W., Wang, L., Wang, H., Xie, W., Yao, S., Lin, Y., et al. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/185715 · Cited by 56
“RvD1, generated through sequential oxygenation of DHA, can reduce human polymorphonuclear leukocyte (PMN) transendothelial migration and inflammatory pain [22].”
BackgroundClinical studies and anti‐inflammatory mechanisms of treatments
French, J. A., Koepp, M. J., Naegelin, Y., Vigevano, F., Auvin, S., Rho, J. M., Rosenberg, E. C., Devinsky, O., Olofsson, P. S., & Dichter, M. A. (2017) · Epilepsia · doi:10.1111/epi.13779 · Cited by 58
“(DHA, 22:6n-3), also exert anti-inflammatory actions, primarily through their hydroxylated metabolites, which include resolvins and docosanoids.(61) Furthermore, PUFAs can bind to and activate peroxisome proliferator-activated receptors (PPARs), including both PPARa and PPARc.”
BackgroundInflammatory Process and Molecular Targets for Antiinflammatory Nutraceuticals.
Huang, M.-T., Ghai, G., & Ho, C.-T. (2004) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2004.tb00063.x · Cited by 54
Metadata
- Authors
- Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 17
- Pages
- 14677-14687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082649626
- Cited by
- 1,000
- References
- 53
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 24 · 2021: 42 · 2020: 36 · 2019: 51 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 59 · 2014: 66 · 2013: 63 · 2012: 48
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6388 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK60583, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- docosahexaenoic acid, docosanoids, omega-3 fatty acids, leukocyte infiltration, glial cells, cytokine production, inflammation resolution, epoxide intermediate, lipidomics, brain, leukocytes, leukotriene biosynthesis
- MeSH terms
- Animals, Blood, Brain, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Humans, Inflammation, Leukocytes, Neuroglia, Mass Spectrometry, Tumor Necrosis Factor-alpha, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.